| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |